Literature DB >> 26782690

Significant improvements in quality of life following paediatric tonsillectomy: a prospective cohort study.

G Thong1, K Davies2, E Murphy3, I Keogh2.   

Abstract

BACKGROUND: The clinical efficacy of adenotonsillectomy is under debate with falling tonsillectomy rates in the UK and Ireland. In 2010, an NHS commissioned randomised controlled trial recommended medical management, leading to some Primary Care Trusts refusing to commission any tonsillectomies at all. With the HSE cutting Hospital Spending by €200 million euro in 2014, data supporting the benefit of adenotonsillectomy in the Irish population are sorely lacking. AIMS: We aimed to evaluate the symptomatic benefit reported by parents of children undergoing adenotonsillectomy/tonsillectomy in the Irish population.
METHODS: We utilised the T14 Paediatric Throat disorders Outcome Test, a disease-specific, validated questionnaire which assesses patient reported outcome measures (PROMs). We administered pre and post-operative questionnaires to parents of children ages 3-16 years undergoing tonsillectomy. Symptomatic children on our tonsillectomy waiting list were also simultaneously recruited. RESULT: Eighty-six children were recruited. A total of 55 parents of children undergoing tonsillectomy filled questionnaires. These were well matched in age and gender with 31 children on the waiting list. An independent samples t test was conducted to compare the improvement scores for tonsillectomy and control groups. There was a significant difference in scores for the tonsillectomy group, with pre-operative scores of (M = 39.8, SD = 9.7) and at post-operative follow-up of (M = 1.6, SD = 7.3) t (61) = -18, p ≤ 0.0001 (two tailed). This correlated with a significant difference in the mean between the two periods (mean difference = 38.3, 95 % CI: 42.3-34.1).
CONCLUSION: This study provides clear evidence that tonsillectomy provides significant improvement in PROMs vs. watchful waiting. We consider tonsillectomy to be a procedure of considerable clinical benefit and a worthwhile allocation of HSE expenditure.

Entities:  

Keywords:  Adenoidectomy; Paediatric; Patient reported outcome measures; Quality of life; Tonsillectomy

Mesh:

Year:  2016        PMID: 26782690     DOI: 10.1007/s11845-016-1398-6

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  15 in total

1.  Application of the Paediatric Throat Disorders Outcome Test (T-14) for tonsillectomy and adenotonsillectomy.

Authors:  K Konieczny; T C Biggs; S Caldera
Journal:  Ann R Coll Surg Engl       Date:  2013-09       Impact factor: 1.891

2.  Quality of life and health status in pediatric tonsil and adenoid disease.

Authors:  M G Stewart; E M Friedman; M Sulek; G F Hulka; R B Kuppersmith; W C Harrill; M H Bautista
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-01

3.  The application and value of the 'T-14 tool' as a patient-reported outcome measure for paediatric tonsillectomy: a report on 45 cases.

Authors:  N Dawe; S Erskine; J W Moor
Journal:  Clin Otolaryngol       Date:  2015-02       Impact factor: 2.597

4.  Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials.

Authors:  J L Paradise; C D Bluestone; R Z Bachman; D K Colborn; B S Bernard; F H Taylor; K D Rogers; R H Schwarzbach; S E Stool; G A Friday
Journal:  N Engl J Med       Date:  1984-03-15       Impact factor: 91.245

5.  Quality of life after adenotonsillectomy in children with obstructive sleep apnea: short-term and long-term results.

Authors:  Chia-Hsuan Lee; Kun-Tai Kang; Wen-Chin Weng; Pei-Lin Lee; Wei-Chung Hsu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-12-16       Impact factor: 1.675

6.  Day-case tonsillectomy: practical solution or practical impossibility.

Authors:  N Kharytaniuk; R Ali; A Sharafa; I J Keogh
Journal:  Ir Med J       Date:  2015-01

7.  The 14-item Paediatric Throat Disorders Outcome Test: a valid, sensitive, reliable, parent-reported outcome measure for paediatric throat disorders.

Authors:  C Hopkins; J Fairley; M Yung; I Hore; S Balasubramaniam; M Haggard
Journal:  J Laryngol Otol       Date:  2010-01-06       Impact factor: 1.469

8.  A two-year follow-up observational study of the T-14 paediatric throat disorders outcome measure in tonsillectomy and adenotonsillectomy.

Authors:  K M Konieczny; T C Biggs; M B Pringle
Journal:  Ann R Coll Surg Engl       Date:  2015-07       Impact factor: 1.891

9.  The role of tonsillectomy for recurrent sore throats in children: a qualitative study.

Authors:  James Barraclough
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-09-06       Impact factor: 1.675

10.  The rising rate of admissions for tonsillitis and neck space abscesses in England, 1991-2011.

Authors:  A S Lau; N S Upile; M D Wilkie; S C Leong; A C Swift
Journal:  Ann R Coll Surg Engl       Date:  2014-05       Impact factor: 1.891

View more
  4 in total

Review 1.  Tonsillectomy for Obstructive Sleep-Disordered Breathing: A Meta-analysis.

Authors:  Sivakumar Chinnadurai; Atia K Jordan; Nila A Sathe; Christopher Fonnesbeck; Melissa L McPheeters; David O Francis
Journal:  Pediatrics       Date:  2017-01-17       Impact factor: 7.124

Review 2.  Tonsillectomy Versus Watchful Waiting for Recurrent Throat Infection: A Systematic Review.

Authors:  Anna Morad; Nila A Sathe; David O Francis; Melissa L McPheeters; Sivakumar Chinnadurai
Journal:  Pediatrics       Date:  2017-01-17       Impact factor: 7.124

Review 3.  Impact of adenotonsillectomy on pediatric quality of life: review of the literature.

Authors:  Sara Torretta; Chiara Rosazza; Maria Elisabetta Pace; Elisabetta Iofrida; Paola Marchisio
Journal:  Ital J Pediatr       Date:  2017-11-25       Impact factor: 2.638

4.  Health Related Quality of Life T-14 Outcomes for Pediatric Bizact Tonsillectomy.

Authors:  Lia Stepan; Lucy Huang; Julie Huynh; Phillip Xie; Charmaine M Woods; Eng H Ooi
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.